Article Text
Abstract
A 46-year-old man presented with worsening vision in the context of long-standing optic disc changes, bilateral sensorineural hearing loss, chronic aseptic meningitis, rash, arthralgia and raised inflammatory markers. The differential diagnoses of neoplasia, infection and inflammation are discussed. We highlight a condition that can present to adult neurologists, with successful diagnosis leading to targeted treatments that transform patient outcomes. This case was presented at the Association of British Neurologists Annual Meeting 2020 as a Clinicopathological Conference (CPC).
- vision
- neurogenetics
- neuroimmunology
- neuro-ophthalmology
- vasculitis
Statistics from Altmetric.com
Footnotes
Contributors All authors fulfil ICJME criteria for authorship. All authors were involved in conception and design of the study, and acquisition and analysis of data, and have reviewed the manuscript. PMF drafted the manuscript and figures.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed by Neil Scolding, Bristol, UK.
Read the full text or download the PDF:
Other content recommended for you
- Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)
- Cryopyrin-associated periodic syndrome: a treatable genetic inflammatory condition
- Systematic evaluation of nine monogenic autoinflammatory diseases reveals common and disease-specific correlations with allergy-associated features
- Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry
- Autoinflammatory syndromes in neurology: when our first line of defence misbehaves
- Familial Mediterranean fever (FMF) and beyond: a new horizon. Fourth International Congress on the Systemic Autoinflammatory Diseases held in Bethesda, USA, 6–10 November 2005
- The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist
- Cutaneous signs and mechanisms of inflammasomopathies
- Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes
- Inheritance of autoinflammatory diseases: shifting paradigms and nomenclature